Tonix pharmaceuticals holding corp. (TNXP)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-29,658

-28,618

-27,499

-25,140

-25,387

-26,089

-23,994

-24,301

-22,994

-21,123

-23,112

-24,904

-29,930

-38,842

-44,720

-50,392

-52,349

-48,054

-43,683

-37,852

-32,133

-27,616

-22,334

-18,005

-14,047

-10,884

-9,806

-8,448

-9,436

-9,450

-8,406

-7,689

-4,971

-3,470

0

0

0

Depreciation and amortization

23

26

32

40

48

54

63

66

61

70

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

54

36

20

18

17

17

15

15

15

14

12

10

9

9

0

0

0

Amortization and write off of deferred financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

196

249

249

249

53

0

0

0

Non cash interest, consisting of beneficial conversion feature in connection with convertible debentures

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

283

710

0

0

0

-

-

-

-

Non cash interest, consisting of common stock and warrants issued in connection with convertible debentures

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

344

426

426

81

81

0

0

0

0

Non-cash financing costs related to January and March 2012 financing

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

81

81

81

0

0

0

0

0

0

Warrants issued for services rendered

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

51

30

24

11

0

0

0

0

-

-

-

-

Stock-based compensation

1,512

1,457

1,466

1,555

1,533

1,627

1,572

1,554

1,622

1,790

2,376

2,687

2,937

3,266

3,372

3,490

3,937

4,389

4,384

4,406

3,883

3,088

2,529

2,087

1,878

1,717

1,569

1,470

1,257

865

867

570

395

435

0

0

0

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,224

-1,177

0

0

0

-

-

-

0

Common stock issued in exchange for intellectual property

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

608

608

608

608

0

0

0

0

0

0

0

-8

0

0

0

0

Gain on extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

Changes in operating assets and liabilities:
Prepaid expenses and other

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses

-

-

-

-

-

-

-

-

-

-72

-1,626

-1,329

-2,202

-2,370

367

869

1,393

2,524

1,445

641

1,250

423

650

889

486

204

3

-28

4

122

40

68

42

79

0

0

0

Deferred rent payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

7

53

55

55

43

-5

-8

-7

-5

-4

-3

-3

-2

-1

-0

9

0

0

0

Accounts payable

271

1,663

70

-594

-132

106

665

459

423

424

-561

-761

-1,230

-2,185

-1,479

-819

95

1,583

-12

1,259

595

728

1,468

58

531

-60

289

976

688

132

-159

17

-212

377

0

0

0

Lease liabilities and ROU asset, net

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-3

0

0

0

-32

3

3

3

38

0

0

0

Accrued expenses and other current liabilities

499

462

-426

-311

-606

410

799

259

202

-361

-1,176

-1,604

-916

-2,261

-869

598

518

1,874

1,804

1,335

1,012

729

187

-11

248

856

708

300

240

293

117

290

83

-12

0

0

0

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-47,717

-48,960

-42,528

-38,834

-31,368

-27,829

-22,840

-18,153

-16,157

-11,219

-8,517

0

0

0

-

-

-

-

-

-

-

-

Net cash used in operating activities

-27,367

-26,683

-26,793

-25,070

-25,842

-23,971

-22,074

-22,230

-21,105

-19,128

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,674

-4,932

-4,034

-2,637

0

0

0

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of furniture and fixtures

-

17

11

12

11

6

10

7

7

5

2

2

1

66

116

151

183

118

193

317

317

319

201

50

17

15

8

2

36

36

35

33

0

2

0

0

0

Maturities of marketable securities

-

-

-

-

-

-

-

-

-

7,174

11,074

16,271

16,526

16,615

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Maturities of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase in cash overdraft

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Payment of restricted cash and interest earned on restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0

0

0

0

0

0

0

0

0

Net cash provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-16,566

-19,453

-24,171

-22,371

-438

-390

-392

-274

-122

-17

-15

0

0

0

-

-

-

-

-

-

-

-

Net cash used by investing activities

-

-17

-11

-12

-11

-6

-10

-7

2,473

7,169

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-35

-33

-14

0

0

0

0

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from demand notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

Proceeds from other notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

320

320

500

500

500

500

0

0

0

Proceeds from related party promissory notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

280

0

0

0

-

-

-

-

-

-

-

-

Proceeds from the exercise of warrants

7,474

70

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,661

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds, net of expenses of $711 and $0, from the sale of preferred stock

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Proceeds, net of expenses of $24 as of December 31, 2011 from Convertible Debentures

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

390

390

1,001

1,501

1,501

1,501

0

0

0

Repayment of Convertible Debentures

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

150

0

0

0

-

-

-

-

Proceeds, net of expenses of $1,352 (2013) and $506 (2012), from sale of units consisting of common stock and warrants, respectively

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Proceeds, net of expenses of $1,513 and $0, from sale of common stock and warrants

22,547

5,869

11,266

9,672

12,185

12,714

7,470

4,581

17,935

18,505

22,244

26,101

21,600

20,498

15,641

30,468

18,631

47,685

47,685

36,182

36,236

47,836

47,836

50,696

50,696

10,042

12,587

2,545

2,545

6,933

4,387

4,387

4,387

0

0

0

0

Net cash provided by financing activities

41,603

12,919

22,161

20,567

23,080

23,539

7,470

4,581

17,949

18,519

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,738

6,282

6,547

2,613

0

0

0

Effect of currency rate change on cash

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from the sale of capital stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

44

309

612

0

0

0

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

30,477

18,640

47,694

47,997

36,674

36,859

53,217

57,235

60,087

60,362

14,950

0

0

0

-

-

-

-

-

-

-

-

Effect of currency rate change on cash

-

-

-

-

-

-

-

-20

-7

-5

-21

-23

-30

-11

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net decrease in cash, cash equivalents and restricted cash

14,217

-13,785

-4,649

-4,518

-2,794

-451

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Effect of currency rate change on cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6

-3

-1

-6

-2

-1

0

0

0

-

-

-

-

-

-

-

-

Net (decrease) increase in cash, cash equivalents and restricted cash

-

-

-

-

-

-

-

-

-

-

13,623

19,374

11,473

-277

-17,365

-33,799

-49,754

-19,009

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase in cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

7,384

-1,269

-2,078

1,744

28

1,316

2,499

-24

0

0

0

Supplemental disclosures of cash flow information:
Issuance of common stock under employee benefit plan

-

-

-

-

-

-

-

-

-

-

74

64

64

167

167

203

203

160

160

70

70

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Senior convertible notes exchanged for preferred shares

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

Capital contribution of accrued interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

-

-

-

-

Demand notes together with accrued interest converted into capital stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

-

-

-

-

Common stock issued for deferred financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

144

144

144

144

0

0

0

Exchange of Notes Payable for Convertible Debenture

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

320

320

0

0

0

-

-

-

-

Warrants Liability reclassified to Stockholders' Equity

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,939

3,939

0

0

0

-

-

-

-

Exchange of Convertible Debenture for Units consisting of common stock and warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,635

2,635

0

0

0

-

-

-

-

Warrants issued in connection with January and March 2012 Financing charged to stockholders' deficiency

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Interest paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

2

2

2

35

0

0

0

-

-

-

-

Non-cash financing activities:
Preferred stock deemed dividend

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant deemed dividend

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-